KaloBios Announces New Transparency Measures for Drug Prices

Although it has no drugs on the market, KaloBios Pharmaceuticals has announced that it will limit price increases to the rate of inflation or Consumer Price Index, and will do so no more than once a year.
Source: Drug Industry Daily